Has Hannah Chaudry, MD received payments from drug or device companies?

Yes. Drug and device makers reported $19,838 in general payments to Hannah Chaudry, MD across 123 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Hannah Chaudry, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Hannah Chaudry, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Hannah Chaudry, MD

Interventional Cardiology · Lebanon, NHNPI 1043621113

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (45.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Cordis US CORP. at 55.1% of the total. 2025 is the largest year on record at $13,007, more than ten times the $1,124 reported in 2020.

$19,838in general payments, 2019–2025

Across 123 payments — averaging $161.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Cordis US CORP.$11K
Medtronic$5K
Boston Scientific$1K
Asahi Intecc USA, Inc.$886
Abiomed$816
Teleflex LLC$431
plus $436 from 6 others

What the payments were for

Speaking & faculty fees$9,00045%
Travel & lodging$5,08526%
Food & beverage$5,57428%
Education$1791%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Cordis US CORP.	13	$10,932
Medtronic(2 entities)	61	$5,250
Boston Scientific	14	$1,087
Asahi Intecc USA, Inc.	15	$886
Abiomed	8	$816
Teleflex LLC	3	$431
Verge Medical, Inc.	2	$226
Philips North America LLC	2	$72
Reflow Medical Inc	2	$63
Novo Nordisk	1	$32
Edwards Lifesciences	1	$25
Shockwave Medical, Inc	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,838 in reported general payments places this provider in the 85th percentile of 26 interventional cardiology providers in New Hampshire.

See all interventional cardiology providers in New Hampshire →

Medicare billing

Part B allowed, 2024

$145,038

Medicare patients

355

Services billed

898

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	92	$81,336
JardianceEmpagliflozin	15	$14,801
Repatha SureclickEvolocumab	13	$8,093
XareltoRivaroxaban	13	$7,845
FarxigaDapagliflozin Propanediol	11	$6,219
Metoprolol Succinate	99	$1,547
Atorvastatin Calcium	59	$749
Rosuvastatin Calcium	29	$698
Ranolazine ErRanolazine	12	$603
Diltiazem 24hr Er (Cd)Diltiazem Hcl	14	$568
Isosorbide Mononitrate ErIsosorbide Mononitrate	25	$422
Amlodipine Besylate	24	$348
Furosemide	57	$275
Ezetimibe	14	$216
Nitroglycerin	13	$165

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Lebanon

Eric RothsteinLebanon$20K
James DevriesLebanon$19K
Aaron KaplanLebanon$13K
Bruce FriedmanLebanon$1K
Alina RobertLebanon$1K
John JayneLebanon$96
John RobbLebanon$0
Shahab MoossaviConcord$36K
Nitish SharmaDover$23K
Rodrigo Mendirichaga MaganaDover$21K

See the full list for New Hampshire →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →